Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

September 30, 2018

Conditions
Chronic Obstructive Pulmonary DiseaseCOPDCopd Exacerbation AcuteCOPD Exacerbation
Interventions
DEVICE

Vibrating Mesh Nebuliser

The Aerogen Ultra vibrating mesh nebuliser is an approved 13 485 class II medical device (CE marked) nebuliser licenced for the delivery of physician-prescribed medications for inhalation which are approved for use with a general purpose nebuliser. It has been shown in previous laboratory and clinical studies to have superior drug delivery to standard jet nebulisers.

DEVICE

Standard Hospital Care

"The standard hospital care refers to the nebuliser in clinical use currently throughout Beaumont Hospital and used for the administration of nebulised medications. This is the Hudson micromist small volume nebuliser."

Trial Locations (1)

Unknown

Beaumont Hospital, Dublin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aerogen

INDUSTRY

lead

Beaumont Hospital

OTHER

NCT03286855 - Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter